Let's talk medical research

With technology advancing at a rapid pace, clinical trial sponsors and sites have been forced to rethink the avenues they use to optimize clinical trials. This has become especially apparent during the COVID-19 pandemic — for clinical trials to stay on track, they have to adopt new ways of conducting research while maintaining data integrity and patient safety. At the same time, patient ...

A flare-up is the reappearance of disease symptoms. And for people living with ulcerative colitis (UC), an inflammatory bowel disease (IBD), flare-ups can be unpredictable, lasting hours, days, or weeks.

Biliary tract cancer (which includes intrahepatic cholangiocarcinoma or bile duct cancer, extrahepatic cholangiocarcinoma, and gallbladder cancer) is a rare form of cancer that develops in the bile duct system, which connects the liver, gallbladder, and small intestine, moving bile to the small intestine.

As of September 2020, there have been over 30 million COVID-19 cases worldwide, with nearly 7 million cases in the United States alone. The impact of this global pandemic is widespread, ranging from how we conduct ourselves in public to the ways in which we seek healthcare.

Living with myasthenia gravis, a rare neuromuscular disorder characterized by progressive weakness of the skeletal muscles, can be difficult. The symptoms, which include trouble talking, facial paralysis, difficulty breathing due to muscle weakness, fatigue, drooping of eyelids, and double vision, can make those living with the condition feel very isolated.

Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) that is generally restricted to the colon, causing long-lasting inflammation and ulcers (sores) in your digestive tract.

Maneuvering clinical trial listings can be a daunting task for any patient. In fact, searching for trials has become more and more difficult over the years, largely due to increasingly stringent eligibility requirements. That’s why we created Antidote Match, the first trial matching engine that uses structured data and proprietary algorithms to explore a patient’s eligibility for every trial.

At Antidote, we receive a lot of questions about participating in a clinical trial.

Clinical trial patient recruitment can take a long time, and 80% of clinical trials today are delayed or closed due to difficulty finding patients to take part. If you have the right recruitment strategies in place for your clinical trial, then enrolling patients doesn’t have to slow your research down.

Sickle cell disease (SCD), a genetic condition presented at birth, is a group of inherited red blood cell disorders. SCD affects millions of people worldwide, and while the exact number of people living with SCD in the U.S. is unknown, it is estimated that it affects approximately 100,000 Americans.